Fujian Sanming Juji E-commerce Co., Ltd – Trademark Portfolio

Entity Type: 16

Fujian Sanming Juji E-commerce Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JUVANUTRA. The owner is based in Yong'an, Fujian.

Rm 302, Unit 2, Bldg 9, Lvjing Jiayuan

No. 45 Xianquan Road, Yandong

Yong'an, Fujian 366099 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JUVANUTRA
JUVANUTRA
Registered 2025

Trademark Classifications

Fujian Sanming Juji E-commerce Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Fujian Sanming Juji E-commerce Co., Ltd have?

Fujian Sanming Juji E-commerce Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Fujian Sanming Juji E-commerce Co., Ltd file in?

Fujian Sanming Juji E-commerce Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Fujian Sanming Juji E-commerce Co., Ltd's most well-known trademarks?

Fujian Sanming Juji E-commerce Co., Ltd's registered trademark portfolio includes well-known marks such as JUVANUTRA. These are among 1 currently registered trademark in the portfolio.

What is Fujian Sanming Juji E-commerce Co., Ltd's trademark registration success rate?

Fujian Sanming Juji E-commerce Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.